HOME >> MEDICINE >> NEWS
Study suggests driving restrictions are not necessary for users of methadone, buprenorphine and LAAM

An Australian study in the December issue of Drug and Alcohol Dependence indicates similar simulated driving results in controls and clients stabilized on pharmacotherapy for heroin dependence. Michael Lenne, Greg Rumbold, Jenny Redman, and Tom J Triggs from Monash University, Victoria, Australia and Paul Dietze from Turning Point Alcohol and Drug Centre Inc, Victoria, Australia and the School of Health Sciences, Deakin University, Victoria Australia studied effects of three drugs used to maintain opiate dependence. Some jurisdictions restrict driving while maintained on methadone and there is a possibility that these restrictions might be extended to buprenorphine and levo-alpha-acetyl-methodol (LAAM). Such a restriction may limit use of treatment modalities in clients who drive.

Thirty-four patients stabilized on methadone, LAAM, or buprenorphine for at least 3 months and 21 non-drug using volunteers participated in the study. Practice sessions were permitted on the simulator. Two experimental sessions (50-minute simulation) assessed speed, lateral position, steering wheel angle, and response to a secondary task. Before one of the sessions participants drank ethanol to obtain a targeted blood alcohol level (BAL) of 0.05%.

Simulated driving performance did not differ among the opiate treatment subjects or between opiate treatment subjects and controls. However, impairment was observed in all groups after alcohol consumption. Importantly, the effects of alcohol in producing diminished performance were equal in all groups. Results from this study question the need for the imposition of restricted driving standards on stabilized methadone, buprenorphine, and LAAM patients.


'"/>

Contact: Dr Paul Dietze
pauld@turningpoint.org.au
613-8413-8413
Elsevier
11-Dec-2003


Page: 1

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:5/20/2013)... data mining solutions company for health and wellness, has ... of labeling claims for the composition of probiotic products ... Drug Administration (FDA) and CosmosID conducted side-by-side analysis of ... have been reported at the American Society for Microbiology. ... the identity of species and strains present in the ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... Online education provides the convenience, flexibility and cost-saving ... According to the American Heart Association, 27% of ... to eLearning due to changing economic conditions. The ... budgets, but it is also proven to enhance ... higher retention of content is probable, given the ...
(Date:5/20/2013)... a consequence of diabetic foot ulcer that does not ... situation are very limited. In his doctoral thesis Yue ... of Medical Biochemistry and Biophysics at Ume University presented ... completely change the lives of millions of patients. , ... wounds that largely impair the quality of life in ...
(Date:5/20/2013)... TX (PRWEB) May 20, 2013 ... portfolio of employee benefit, payroll products and services and ... that both are selected as finalists for the 2013 ... Fastest-Growing Company of the Year category, and CompuPay is ... Each finalist will ultimately be a Gold, Silver or ...
Breaking Medicine News(10 mins):Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Discovery of a novel medicine for the treatment of chronic wounds 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3
(Date:5/19/2013)... , May 19, 2013  The non-surgical ... temperature radiofrequency (RF) energy is effective in control ... reduces the need for medication 10 years post-procedure, ... today at the Digestive Disease Week (DDW) meeting ... . "The sustained improvement ...
(Date:5/18/2013)... NEW YORK , May 18, 2013 /PRNewswire/ ... securities law firm, is investigating potential securities fraud ... (NASDAQ: AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ... the Company and its executives violated federal securities ... regarding the Company,s Phase III drug trials for ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, healthcare and to first responders ... its financial results for the fiscal 2013 fourth quarter ... 21, 2013 at stock market close and will conduct ... p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
Cached News: